Follow Us:Follow Us on Twitter Like Us on Facebook Follow Us on Google+ Watch videos on our Youtube channel
The Cedars-Sinai Epilepsy Program offers both consultations and continuous care to patients with seizure disorders. The process of evaluation and treatment for patients with seizures require an interdisciplinary approach. The program is staffed by epileptologists, adult and pediatric epilepsy neurosurgeons, psychiatrists, neuropsychologists, neurodiagnostic technologists, epilepsy nurse specialists and ancillary staff with special expertise in seizure disorders. The program provides clinics, as well as outpatient EEG diagnostic services, including routine EEG screening and monitoring. Comprehensive evaluation and treatment options are offered to patients in close cooperation with the Department of Neurosurgery's Epilepsy Consultatory Specialty Clinic.
About 25 percent of patients with seizure disorders do not respond to medications. Studies have shown that patients whose epilepsy is not controlled with two or three medications have only a four percent likelihood of responding to an additional medication. Patients with medically refractory seizures (seizures that cannot be controlled with medication) are offered an evaluation to assess whether they are candidates for resective (taking out an area of the brain causing seizures) epilepsy surgery.
The program also offers evaluation and management of patients who could be candidates for implantation of devices such as Vagus Nerve Stimulation. Access to magnetoenchephalography (MEG) service is available in collaboration with the Scripps Clinic in San Diego, California.
In addition to offering anti-convulsant medical treatment and surgery, the program continues to stay at the forefront of anti-epileptic drug research.
Cedars-Sinai's Epilepsy Program is recognized by the NAEC as a Level 4 epilepsy center. Level 4 epilepsy centers have the professional expertise and facilities to povide the highest level medical and surgical evaluation and treatment for patients with complex epilepsy.